UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preventing nonsteroidal anti-inflammatory drug–induced small-bowel injury: the saga continues

Gastrointestinal endoscopy, 2009-06, Vol.69 (7), p.1347-1349

2009

Volltextzugriff (PDF)

Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia

Journal of clinical gastroenterology, 2008-08, Vol.42 (7), p.844-848

2008

Volltextzugriff (PDF)

231 Upper and Lower Gastrointestinal Safety Profile of Celecoxib: Patient-Level Pooled Analysis of 51,048 Patients in Randomized, Double-Blinded, Parallel-Group Clinical Trials

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-44-S-44

2010

Volltextzugriff (PDF)

Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis

European journal of gastroenterology & hepatology, 2002-10, Vol.14 (10), p.1101-1111

2002

Volltextzugriff (PDF)

W1831 The Association Between the Small Intestinal Bacterial Overgrowth and the use of Proton Pump Inhibitors, H2 Blockers, Narcotic Analgesics, and Anticholinergics

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-749-S-749

2010

Volltextzugriff (PDF)

M1333 Irritable Bowel Syndrome and the Association With Small Intestinal Bacterial Overgrowth: Putting the Concept in Perspective

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-382-S-382

2010

Volltextzugriff (PDF)

PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

The Lancet (British edition), 1988-12, Vol.332 (8623), p.1277-1280

1988

Volltextzugriff (PDF)

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole

Archives of internal medicine (1960), 2002-01, Vol.162 (2), p.169

2002

Volltextzugriff (PDF)

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

The American journal of gastroenterology, 2000-07, Vol.95 (7), p.1681-1690

2000

Volltextzugriff (PDF)

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

The American journal of gastroenterology, 2000-07, Vol.95 (7), p.1681-1690

2000

Volltextzugriff (PDF)

Superiority of Lansoprazole vs Ranitidine in Healing Nonsteroidal Anti-inflammatory Drug–Associated Gastric Ulcers: Results of a Double-blind, Randomized, Multicenter Study

Archives of internal medicine (1960), 2000-05, Vol.160 (10), p.1455

2000

Volltextzugriff (PDF)

Delayed-Release Lansoprazole plus Naproxen: A Viewpoint by Naurang M. Agrawal

Drugs (New York, N.Y.), 2004-09, Vol.64 (17), p.1920-1921

Agrawal, Naurang M

2004

Volltextzugriff (PDF)

HIV-1 gp41 antigen demonstration in esophageal ulcers with acquired immunodeficiency syndrome

Journal of clinical gastroenterology, 1991-12, Vol.13 (6), p.644-648

1991

Volltextzugriff (PDF)

Delayed-release lansoprazole plus naproxen. Commentaries

Drugs (New York, N.Y.), 2004, Vol.64 (17), p.1915-1921

2004

Volltextzugriff (PDF)

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

Annals of internal medicine, 1991-08, Vol.115 (3), p.195-200

1991

Volltextzugriff (PDF)

Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs

Journal of rheumatology. Supplement, 1998-05, Vol.51, p.17

1998

Volltextzugriff (PDF)

Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage

Gastrointestinal endoscopy, 1986-04, Vol.32 (2), p.67-70

1986

Volltextzugriff (PDF)

Comparison of the upper gastrointestinal safety of arthrotec ® 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

Clinical therapeutics, 1999-04, Vol.21 (4), p.659-674

1999

Volltextzugriff (PDF)

A RATIONALE FOR APPROPRIATE USE OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS INSTEAD OF NSAIDs BASED ON RISK FACTORS FOR ADVERSE GASTROINTESTINAL EVENTS

Evidence-based gastroenterology, 2003-05, Vol.4 (2), p.39-40

2003

Volltextzugriff (PDF)

Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers : a one-year study

Digestive diseases and sciences, 1995-05, Vol.40 (5), p.1125-1131

1995

Volltextzugriff (PDF)

Misoprostol in the Treatment and Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Gastrointestinal Mucosal Injury

Canadian journal of gastroenterology, 1990, Vol.4 (3), p.120-125

Agrawal, Naurang M

1990

Volltextzugriff (PDF)

Development of a scoring system for predicting upper gastrointestinal distress

Gastroenterology (New York, N.Y. 1943), 2000-04, Vol.118 (4), p.A249-A249

2000

Volltextzugriff (PDF)

Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs

Digestive diseases (Basel), 1995-01, Vol.13 Suppl 1, p.48

1995

Volltextzugriff (PDF)

Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases

The American journal of managed care, 1998-03, Vol.4 (3), p.399-409

1998

Volltextzugriff (PDF)

Prevention of IMonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Ulcers: Role of Mucosal Protective and Gastric Antisecretory Drugs

Digestive diseases (Basel), 1995, Vol.13 (1), p.48-61

1995

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(43)
Reviews
(1)

Sprache

Englisch
(44)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Male
(18)
Middle Aged
(16)
Adult
(15)
Biological And Medical Sciences
(14)
Gastroenterology & Hepatology
(14)
Medical Sciences
(14)
Pharmacology. Drug Treatments
(11)
Aged
(10)
Female
(10)
Anti-Inflammatory Agents, Non-Steroidal - Adverse Effects
(9)
Double-Blind Method
(7)
Misoprostol
(7)
Drug Toxicity And Drugs Side Effects Treatment
(6)
Toxicity: Digestive System
(6)
Digestive System
(5)
Gastric Mucosa - Drug Effects
(5)
General & Internal Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preventing nonsteroidal anti-inflammatory drug–induced small-bowel injury: the saga continues

Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia

231 Upper and Lower Gastrointestinal Safety Profile of Celecoxib: Patient-Level Pooled Analysis of 51,048 Patients in Randomized, Double-Blinded, Parallel-Group Clinical Trials

Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis

W1831 The Association Between the Small Intestinal Bacterial Overgrowth and the use of Proton Pump Inhibitors, H2 Blockers, Narcotic Analgesics, and Anticholinergics

M1333 Irritable Bowel Syndrome and the Association With Small Intestinal Bacterial Overgrowth: Putting the Concept in Perspective

PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

Superiority of Lansoprazole vs Ranitidine in Healing Nonsteroidal Anti-inflammatory Drug–Associated Gastric Ulcers: Results of a Double-blind, Randomized, Multicenter Study

Delayed-Release Lansoprazole plus Naproxen: A Viewpoint by Naurang M. Agrawal

HIV-1 gp41 antigen demonstration in esophageal ulcers with acquired immunodeficiency syndrome

Delayed-release lansoprazole plus naproxen. Commentaries

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs

Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage

Comparison of the upper gastrointestinal safety of arthrotec ® 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

A RATIONALE FOR APPROPRIATE USE OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS INSTEAD OF NSAIDs BASED ON RISK FACTORS FOR ADVERSE GASTROINTESTINAL EVENTS

Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers : a one-year study

Misoprostol in the Treatment and Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Gastrointestinal Mucosal Injury

Development of a scoring system for predicting upper gastrointestinal distress

Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs

Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases

Prevention of IMonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Ulcers: Role of Mucosal Protective and Gastric Antisecretory Drugs

Suchergebnisse filtern